Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Jaspamycin (7-CN-7-C-Ino) does not bind with purified human PKARIα. Anti-parasite activity. Jaspamycin (7-CN-7-C-Ino) is a potent activator of PKA, binding to the R site (PKAR), with an EC50 of 6.5 nM and Kd of 8 nM in Trypanosoma brucei.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 6-8 weeks | $ 297.00 | |
25 mg | 6-8 weeks | $ 987.00 | |
50 mg | 6-8 weeks | $ 1,360.00 | |
100 mg | 6-8 weeks | $ 1,860.00 | |
1 mL * 10 mM (in DMSO) | 6-8 weeks | $ 318.00 |
Description | Jaspamycin (7-CN-7-C-Ino) does not bind with purified human PKARIα. Anti-parasite activity. Jaspamycin (7-CN-7-C-Ino) is a potent activator of PKA, binding to the R site (PKAR), with an EC50 of 6.5 nM and Kd of 8 nM in Trypanosoma brucei. |
Targets&IC50 | PKA holoenzyme (T. b. brucei):8 nM (Kd), PKAR (T. b. brucei):6.5 nM (EC50) |
Synonyms | 7-CN-7-C-Ino |
Molecular Weight | 292.25 |
Formula | C12H12N4O5 |
CAS No. | 22242-96-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 41.67 mg/mL (142.58 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Jaspamycin 22242-96-2 Angiogenesis Chromatin/Epigenetic JAK/STAT signaling Stem Cells JAK 7-CN-7-C-Ino inhibitor inhibit